I got pancreatic cancer at the age of 20, whether to persist or give up

Of course, we can't give up, although pancreatic cancer is known as the king of cancer, but it is not a disease that cannot be saved, through positive **, even if pancreatic cancer cannot be cured in the end, the purpose of prolonging the survival of patients can still be achieved, we live in this world, we don't know when we will leave, but we should all strive to live longer, longer. Jobs's pancreatic cancer was diagnosed with 8 years to live, and he didn't control it very well, otherwise he would have had a chance to live longer. According to the different stages of the tumor, patients can be surgical, radiotherapy, chemotherapy, during the ** period, patients can take ginseng, it can reduce the toxicity of the drug, can improve the patient's immunity, improve the patient's weak constitution.

Pancreatic cancer has a poor prognosis due to its high degree of malignancy and low surgical resection rate. Although surgery is still the primary method, pancreatic cancer is often detected late and the opportunity is lost, so pancreatic cancer needs to be comprehensive. To date, as with most tumors, there is no comprehensive protocol that is highly effective and fully applicable.

At present, the comprehensive method is still based on surgery, supplemented by radiotherapy and chemotherapy, and combined with immunological and molecular biology.

Pancreatic cancer is a common malignant tumor of the digestive system, which can have no symptoms in the early stage, and as the tumor progresses, there can be abdominal pain and abdominal distension and other digestive symptoms. Pancreatic cancer generally occurs in middle-aged and older patients, and young men in their 20s are generally less likely to have pancreatic cancer.

For pancreatic cancer patients, the ** that undergoes the sixth-generation Cyberknife is undoubtedly a pretty good choice. The effect of the sixth generation CyberKnife ** pancreatic cancer is still very good, especially in the control of tumors, this technology can greatly improve its accuracy, thereby improving the efficacy, prolonging the survival of patients to a certain extent, improving the survival rate, and improving the survival rate at the same time, but also reducing the radiation damage of normal tissues around the lungs.

Cancer is age-free, meaning it can be acquired at any age.

1. Of course, most cancer patients only start to get cancer after the age of 45.

2. The younger the age, the lower the rate of developing cancer. As for the 22-year-old landlord said, generally speaking, under normal life (no human in vivo experiments during the invasion of China, as well as special serious environmental pollution, or poor living environment since childhood......and so on), and it can be said that the probability of acquiring any cancer can be considered "zero".

3. Because the acquisition of cancer is not the acquisition of a certain virus, it generally requires a long process (time) under the assistance of catalysis without special conditions. In other words, at the age of 22, he has not yet begun to "experience", **knows the "ups and downs of life", and **has endured "real suffering", so it is basically impossible to get cancer.

For advanced pancreatic cancer, the length of survival depends on the patient's age, gender, physique, living habits, diet, psychological factors, degree of disease and later conditions.

Once pancreatic cancer is detected, it is necessary to see a doctor in time, otherwise the prognosis of the disease is very poor, and only a very small number of pancreatic cancer patients can survive for 5 years after diagnosis. For those whose cancer has not spread, the only hope is surgery, which removes the pancreas or pancreas and duodenum. Even with such surgery, only 10 out of 10 patients survive for 5 years, no matter how much further it goes.

**Proper approach is the most important factor in how long you can live with advanced pancreatic cancer. Pancreatic cancer is a systematic process involving many factors, in general, how long the survival time of patients with advanced pancreatic cancer mainly depends on whether the method is appropriate and the patient's physical function. In addition, patients with advanced pancreatic cancer and their families should learn more about the advanced stage of pancreatic cancer, and communicate more with the attending physician. Only with good physical function and strong immunity can we resist the development of cancer and prolong life. Rh2 has a certain inhibitory effect on tumors, which can improve human immunity, reduce the toxicity of chemotherapy drugs, and improve the quality of life and prolong the survival time for advanced patients.

First of all, pancreatic cancer has a low rate of early diagnosis. It is not clear which risk factors are for the development of pancreatic cancer. Pancreatic cancer also has no specific clinical manifestations and tumor markers, and the imaging features are atypical.

Pancreatic cancer stage I patients only account for the low rate of pancreatic cancer surgical resection, and more than 80 pancreatic cancer patients can only undergo exploratory or palliative surgery when diagnosed, and only 5 30 can be resectedIn addition, it is difficult to distinguish pancreatic cancer from chronic pancreatitis. Postoperative metastasis is early and has a high incidence.

The efficacy of radiotherapy or chemotherapy alone is not satisfactory and the prognosis is extremely poor.

For pancreatic cancer**, the use of a single surgery, radiotherapy and a single chemotherapy have not been satisfactory results, at present, it is still mainly surgery, the 5-year survival rate of small pancreatic cancer without lymph node metastasis is 23, but the 5-year survival rate of most pancreatic cancers larger than 2cm is almost equal to zero. Therefore, the involvement of chemotherapy and radiation** must be considered.

Preoperative radiation therapy is more sensitive, which can improve the thoroughness of surgical resection and reduce tumor spread.

Intraoperative radiotherapy uses a large dose of irradiation, necrosis of the tumor center, tissue degeneration, tumor shrinkage, and the average survival time of unresected tumors after intraoperative radiotherapy is 9 months, and there is also analgesic effect.

After surgery, multi-field continuous or multi-field segmental irradiation was used, and the median survival of patients was 4 to 16 months. For tumors that cannot be resected, several hollow source tubes can also be placed during the operation, and the abdominal wall can be drawn out, and the postoperative close-up machine can be used for inter-tissue irradiation. From 1986 to 1997, 53 cases of advanced pancreatic cancer were radiated from the Cancer Hospital of the Chinese Academy of Medical Sciences, with a median survival of 6 months.

Perioperative chemotherapy is systemic and regional. In terms of medication time, it can be divided into preoperative chemotherapy and postoperative chemotherapy. The combination has a short-term response rate compared with monotherapy, but has no significant effect on survival and increases toxicity.

Regional chemotherapy, in which anticancer drugs are injected into the arteries supplied by the pancreas with a cannula, is still being studied. The reasons for the failure of chemotherapy for pancreatic cancer are mostly related to drug resistance, and the mechanism of drug resistance and the strategy of reversal have been studied.

In addition, biology, genes, etc., are still in the exploration stage.

In summary, the diagnosis of pancreatic cancer requires multidisciplinary collaboration such as biochemistry, immunology, imaging, endoscopy, and histocytology in addition to surgery, internal medicine, and radiology.

At present, among the strategies for the diagnosis and treatment of pancreatic cancer vigorously advocated at home and abroad, special emphasis is placed on the screening of sub-healthy populations, and the follow-up of high-risk groups screened.